Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New grid could help detect preemie delays sooner

NCT ID NCT07169110

Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a new observation grid can help doctors and therapists consistently identify early signs of developmental problems in very premature babies (born at 27-32 weeks). Researchers will film 35 infants at home and have different professionals rate their development using the grid. The goal is to create a reliable tool for very early detection, so these vulnerable babies can get the right support as soon as possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be selected from infants born and hospitalized in the neonatology department of Toulouse University Hospital. The study targets a local population, with families residing within a 15-kilometer radius of Toulouse to allow for home-based video recording.

Ages

1 month to 6 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female child born between 27 and 32 weeks of amenorrhea in a singleton pregnancy; * Child hospitalized in the neonatology unit of Toulouse University Hospital; * Family home within a 15 km radius of Toulouse to allow for home visits for filming; * Parents with parental authority affiliated with a social security scheme or equivalent; * Signature of the informed consent form by the parents with parental authority * Absence of serious illness, as defined in the exclusion criteria; * The child may participate in another study during the duration of this study, without an exclusion period. Exclusion Criteria: * Child with a severe organic pathology detected during hospitalization and requiring specific and appropriate care for the diagnosed pathology; * Child with a neurological complication: Grade 3 or 4 intraventricular hemorrhage, periventricular cavitary leukomalacia, excluding frontal leukomalacia; * Child with a malformation or multiple malformations that impair the neurological prognosis; * Child with genetic or metabolic diseases; * Fetal alcohol syndrome; * Parental authority holders under guardianship, curatorship, or legal protection; * Any family condition that prevents compliance with the procedures set out in the study protocol, in the opinion of the investigator. * Family members who do not speak French fluently, in order to ensure understanding of the system and the proposed care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Evaluation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Evaluation Health care quality Outcome Premature infant Prematurity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Intensive care /neonatology Toulouse Hospital

    Toulouse, 31000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.